Perbedaan Organon Pharma Indonesia Tbk. dan Tembaga Mulia Semanan Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Tembaga Mulia Semanan Tbk. diperdagangkan di Rp1.225 (kapitalisasi pasar 914,68 M, volume 24 jam 27,3 rb). Perbedaan utamanya: Tembaga Mulia Semanan Tbk. jauh lebih besar — sekitar 8,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TBMS | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 914,68 M |
Volume | — | 27,3 rb |
Lot | — | 273 |
Perputaran | — | 33,53 jt |
Harga Rata-rata | — | 1.228,15 |
Nilai Transaksi | — | 33,53 jt |
Harga Ekuilibrium Indikatif | — | 1.245 |
Volume Ekuilibrium Indikatif | — | 100 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT. Tembaga Mulia Semanan Tbk was incorporated based on the Notarial Deed No. 31 dated February 3, 1977 of Kartini Muljadi, S.H., as amended by Notarial Deed No. 48 dated July 6, 1977 of the same notary. The company has started commercial production since Dec 1979. And started production/assembly of electronics wire/cable in 1993. Drawn wire in 1995 and assembly of optical fibre cable in 1998, tinned copper in 1998.
Selengkapnya di halaman TBMS →